Stock · DHR · Healthcare
United States · Large Cap · listed since 1979 · Revenue 12 mo. $25.6B
Price as of 11/06/2026
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Original text from the data provider
Summary
50.7 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €4.7B (2025), it supports €52.4B. The remaining €95.5B of the market value assume it grows 14.5% a year for 10 years and not at all afterwards.
Required FCF growth per year
14.5%
no growth afterwards
Price to operating cash flow 23.7×, within its usual range.
Middle half of 20 quarters: 22.4× to 25.4×, median 23.1×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q2 → Q3 2026
8 more unchanged: Revenue, 12 mo., FCF, 12 mo., Gross margin, EBIT margin, FCF margin, Net debt, Shares outstanding, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 6.88% | 11.52% | Rank 26 |
| Return on capital (Greenblatt) | 40.47% | 32.55% | Rank 63 |
| EBIT margin | 20.91% | 18.31% | Rank 65 |
| FCF margin | 21.41% | 14.12% | Rank 75 |
| Gross margin | 60.93% | 60.99% | Rank 50 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 2.90% | 8.04% | Rank 22 |
| Earnings growth, 3 years per year | −19.60% | 5.44% | Rank 11 |
| Earnings growth, 5 years per year | 0.04% | 7.00% | Rank 33 |
| Sustainable growth (ROE × retained earnings) | 4.71% | 3.66% | Rank 59 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 2.21% | 2.90% | Rank 33 |
| FCF yield | 3.19% | 3.63% | Rank 40 |
| EV/saleslower is better | 7.27 | 4.03 | Rank 28 |
| EV/EBITlower is better | 34.78 | 21.73 | Rank 19 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | −0.31% | 8.66% | Rank 41 |
| Share price, 6 months | 35.01% | 24.27% | Rank 75 |
| Share price, 3 months | 17.58% | 15.42% | Rank 55 |
| Distance from 52-week high | −4.88% | −7.35% | Rank 59 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −1.99% | 0.30% | Rank 72 |
| Change in share countlower is better | −3.55% | 0.00% | Rank 91 |
| Dividend streak in years | 9 | 10 | Rank 58 |
| Price reaction to results, market-adjusted | 3.76% | 0.05% | Rank 79 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 62.94% | 48.40% | Rank 72 |
| Net debt/EBITDAlower is better | 1.99 | 1.11 | Rank 30 |
| Debt to equitylower is better | 0.35 | 0.48 | Rank 58 |
| Volatility, 1 yearlower is better | 30.17% | 31.42% | Rank 59 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $B | Shares | Net debt, $B |
|---|---|---|---|---|---|
| 2016 | 16.9 | 17.7% | 2.9 | 700M | 11.3 |
| 2017 | 18.3 | 17.2% | 2.9 | 706M | 9.9 |
| 2018 | 17.0 | 18.0% | 3.4 | 710M | 9.0 |
| 2019 | 17.9 | 18.8% | 3.3 | 726M | 2.6 |
| 2020 | 22.3 | 19.4% | 5.4 | 719M | 16.1 |
| 2021 | 29.5 | 27.3% | 7.1 | 737M | 20.7 |
| 2022 | 26.6 | 28.3% | 7.4 | 737M | 14.6 |
| 2023 | 23.9 | 21.8% | 5.8 | 743M | 13.7 |
| 2024 | 23.9 | 21.7% | 5.3 | 737M | 15.1 |
| 2025 | 24.6 | 20.9% | 5.3 | 711M | 13.8 |
2 of 7 StockScorer Score rules met · How the score is built
Danaher Corporation mainly meets criteria in the Profitability category. Result from 18 strategies checked.
Danaher Corporation is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
2 of 7 rules met
4 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Danaher Corporation.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 45.3 | 30.0 |
| P/B ratio | 3.1 | 4.8 |
| Return on equity (ROE) | 6.9% | 11.5% |
| Equity ratio | 62.9% | 48.4% |
| Debt-to-equity (D/E) | 0.35 | 0.48 |
| Dividend yield | 0.7% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| DHR | Danaher Corporationthis page | |
| TMO | Thermo Fisher Scientific Inc | Low4.5 |
| A | Agilent Technologies Inc | Low4.5 |
| NTRA | Natera Inc | locked |
| IQV | IQVIA Holdings Inc | locked |
| WAT | Waters Corporation | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.